Journal of Health Economics and Outcomes Research
@journalheor.bsky.social
An international high-quality, open-access journal covering all fields and methodologies related to health economics and outcomes research. Indexed in PubMed, PubMed Central (PMC), Web of Science Emerging Sources Citation Index, DOAJ, Google Scholar.
New in JHEOR: Digital cognitive behavioral therapy for insomnia significantly reduced healthcare costs by $2083 per person annually, offering a cost-effective alternative to traditional treatments and improving treatment accessibility. #HEOR #insomnia #CBT #DigitalTherapy
November 13, 2025 at 8:26 PM
New in JHEOR: Digital cognitive behavioral therapy for insomnia significantly reduced healthcare costs by $2083 per person annually, offering a cost-effective alternative to traditional treatments and improving treatment accessibility. #HEOR #insomnia #CBT #DigitalTherapy
New in JHEOR: High clinical event rates and monthly costs among U.S. patients with metastatic triple-negative breast cancer on chemotherapy underscore need for safer, more effective treatment options. #HEOR #mTNBC #BreastCancer #TripleNegative
November 6, 2025 at 3:27 PM
New in JHEOR: High clinical event rates and monthly costs among U.S. patients with metastatic triple-negative breast cancer on chemotherapy underscore need for safer, more effective treatment options. #HEOR #mTNBC #BreastCancer #TripleNegative
Reposted by Journal of Health Economics and Outcomes Research
WHO too reliant on funding from donor organizations, paper argues
Researchers say reliance on earmarked voluntary contributions from external donors like the Gates Foundation undermines the WHO's independence.
www.cidrap.umn.edu/p...
Researchers say reliance on earmarked voluntary contributions from external donors like the Gates Foundation undermines the WHO's independence.
www.cidrap.umn.edu/p...
October 30, 2025 at 5:42 PM
WHO too reliant on funding from donor organizations, paper argues
Researchers say reliance on earmarked voluntary contributions from external donors like the Gates Foundation undermines the WHO's independence.
www.cidrap.umn.edu/p...
Researchers say reliance on earmarked voluntary contributions from external donors like the Gates Foundation undermines the WHO's independence.
www.cidrap.umn.edu/p...
Reposted by Journal of Health Economics and Outcomes Research
Hitting rheumatoid arthritis early and hard, with targeted therapies as first-line treatment, appears to reduce the likelihood that it will reach the dreaded "difficult-to-treat" stage, according to studies.
https://www.medpagetoday.com/meetingcoverage/acr/118195
https://www.medpagetoday.com/meetingcoverage/acr/118195
Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?
Studies suggest strategies that may help
www.medpagetoday.com
October 30, 2025 at 7:45 PM
Hitting rheumatoid arthritis early and hard, with targeted therapies as first-line treatment, appears to reduce the likelihood that it will reach the dreaded "difficult-to-treat" stage, according to studies.
https://www.medpagetoday.com/meetingcoverage/acr/118195
https://www.medpagetoday.com/meetingcoverage/acr/118195
New study in JHEOR evaluates the cost savings for NHS England from switching inappropriate long-term PPI users to episodic alginate therapy. #HEOR #GERD #NHSEngland
October 30, 2025 at 8:33 PM
New study in JHEOR evaluates the cost savings for NHS England from switching inappropriate long-term PPI users to episodic alginate therapy. #HEOR #GERD #NHSEngland
New study in JHEOR evaluates how accurately an LLM could assess economic study quality using the CHEERS checklist, compared with human reviewers. #LLM #HEOR #LargeLanguageModels #CHEERS #HealthEconomics
October 24, 2025 at 2:12 PM
New study in JHEOR evaluates how accurately an LLM could assess economic study quality using the CHEERS checklist, compared with human reviewers. #LLM #HEOR #LargeLanguageModels #CHEERS #HealthEconomics
New study estimates healthcare costs of non-HIV comorbidities in people living with HIV in Spain, highlighting the growing financial and clinical impact of toxicity with antiretroviral therapies. #HIV #HEOR #PLWH #antiretrovirals
October 23, 2025 at 6:17 PM
New study estimates healthcare costs of non-HIV comorbidities in people living with HIV in Spain, highlighting the growing financial and clinical impact of toxicity with antiretroviral therapies. #HIV #HEOR #PLWH #antiretrovirals
Reposted by Journal of Health Economics and Outcomes Research
🚨So important to take steps to clean up knowledge base!
Journals & publishers crack down on research from open health data sets www.science.org/content/arti...
"...following revelations that unscrupulous actors use these data sets to churn out nonsense scientific papers."
Journals & publishers crack down on research from open health data sets www.science.org/content/arti...
"...following revelations that unscrupulous actors use these data sets to churn out nonsense scientific papers."
Journals and publishers crack down on research from open health data sets
PLOS, Frontiers, and others announce policies trying to stem the tide of suspect research
www.science.org
October 21, 2025 at 4:03 PM
🚨So important to take steps to clean up knowledge base!
Journals & publishers crack down on research from open health data sets www.science.org/content/arti...
"...following revelations that unscrupulous actors use these data sets to churn out nonsense scientific papers."
Journals & publishers crack down on research from open health data sets www.science.org/content/arti...
"...following revelations that unscrupulous actors use these data sets to churn out nonsense scientific papers."
New study: Drone-based aerial logistics for improving material and newborn health in sub-Saharan Africa can be a cost-effective, scalable intervention. #MaternalChildHealth #sub-SaharanAfrica #AerialLogistics #drones
October 15, 2025 at 2:37 PM
New study: Drone-based aerial logistics for improving material and newborn health in sub-Saharan Africa can be a cost-effective, scalable intervention. #MaternalChildHealth #sub-SaharanAfrica #AerialLogistics #drones
New research in JHEOR explores the incidence and mortality of meningitis, pneumonia, and bacteremia among adults in Colombia using health system data from 2015 to 2022. #HEOR #infectious disease #publichealth
October 10, 2025 at 5:31 PM
New research in JHEOR explores the incidence and mortality of meningitis, pneumonia, and bacteremia among adults in Colombia using health system data from 2015 to 2022. #HEOR #infectious disease #publichealth
Bariatric surgery associated with greater weight loss and lower ongoing costs than GLP-1 RAs.
Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists
This cohort study uses a large US insurance claims database to assess weight loss and ongoing costs associated with metabolic bariatric surgery vs glucagon-like peptide-1 receptor agonists.
jamanetwork.com
October 3, 2025 at 7:45 PM
Bariatric surgery associated with greater weight loss and lower ongoing costs than GLP-1 RAs.
Reposted by Journal of Health Economics and Outcomes Research
Interested in writing about chronic disease management but need funding? The #NIHCM Journalism Grants Program is taking grant applications on a curated list of topic areas. Learn more about eligibility requirements and apply today: bit.ly/JGrants25 | #chronicdisease #journalism #grants
September 26, 2025 at 5:45 PM
Interested in writing about chronic disease management but need funding? The #NIHCM Journalism Grants Program is taking grant applications on a curated list of topic areas. Learn more about eligibility requirements and apply today: bit.ly/JGrants25 | #chronicdisease #journalism #grants
Reposted by Journal of Health Economics and Outcomes Research
This is interesting — in a paper out today, researchers created an alternate history to estimate what Trump's desired cuts to NIH would look like. Of 557 drugs approved 2000-2023, *more than half* are at least partially linked to NIH research that would have not happened under a 40% reduction.
What if NIH had been 40% smaller?
Replaying history with less NIH funding shows widespread impacts on drug-linked research
www.science.org
September 25, 2025 at 7:04 PM
This is interesting — in a paper out today, researchers created an alternate history to estimate what Trump's desired cuts to NIH would look like. Of 557 drugs approved 2000-2023, *more than half* are at least partially linked to NIH research that would have not happened under a 40% reduction.
Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing for patients through the end of 2026.
AHIP Statement on Vaccine Coverage
AHIP is the national association whose members provide health care coverage, services, and solutions to hundreds of millions of Americans every day. We…
www.ahip.org
September 17, 2025 at 2:02 PM
Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing for patients through the end of 2026.
Using a database of abortion provider locations and operations in Texas from 2009–2019, this paper exploits variation in travel distance to the nearest facility created by clinic closures following the enforcement of Texas HB-2 in 2013.
#abortionaccess #texas #economics
#abortionaccess #texas #economics
Abortion, Economic Hardship, and Crime
Founded in 1920, the NBER is a private, non-profit, non-partisan organization dedicated to conducting economic research and to disseminating research findings among academics, public policy makers, an...
www.nber.org
September 15, 2025 at 8:15 PM
Using a database of abortion provider locations and operations in Texas from 2009–2019, this paper exploits variation in travel distance to the nearest facility created by clinic closures following the enforcement of Texas HB-2 in 2013.
#abortionaccess #texas #economics
#abortionaccess #texas #economics
Is "reasonable cost" associated with source of payment? Are pricing models for public plans, commercial insurance, and lien-based payments disconnected? New research in JHEOR illustrates the variations in cost. #heor #Medicare #HealthcareProviders #survey
jheor.org/article/1434...
jheor.org/article/1434...
September 8, 2025 at 6:31 PM
Is "reasonable cost" associated with source of payment? Are pricing models for public plans, commercial insurance, and lien-based payments disconnected? New research in JHEOR illustrates the variations in cost. #heor #Medicare #HealthcareProviders #survey
jheor.org/article/1434...
jheor.org/article/1434...
Monitoring calls to the national 2-1-1 helpline may allow data scientists to respond proactively to potential problems.
Rich trove of data on social needs waits to be tapped - WashU School of Public Health
211 Counts’ real-time data on Americans’ calls for help could provide early warning of emerging problems
schoolofpublichealth.washu.edu
September 3, 2025 at 1:29 PM
Monitoring calls to the national 2-1-1 helpline may allow data scientists to respond proactively to potential problems.
New study highlights the value of effective 1L therapy for EGFR-mutated non-small cell lung cancer. #HEOR #lungcancer #osimertinib
August 29, 2025 at 4:39 PM
New study highlights the value of effective 1L therapy for EGFR-mutated non-small cell lung cancer. #HEOR #lungcancer #osimertinib
New research explores differences in metrics such as treatment patterns, HCRU, and costs between patients with BRCA mutant and wildtype tumors. #OvarianCancer #HEOR #BRCA
August 26, 2025 at 8:11 PM
New research explores differences in metrics such as treatment patterns, HCRU, and costs between patients with BRCA mutant and wildtype tumors. #OvarianCancer #HEOR #BRCA
New research explores the cost-effectiveness of Acthar Gel, an FDA-approved repository corticotropin injection, as an alternative treatment of nephrotic syndrome due to idiopathic membranous nephropathy.
August 7, 2025 at 6:24 PM
New research explores the cost-effectiveness of Acthar Gel, an FDA-approved repository corticotropin injection, as an alternative treatment of nephrotic syndrome due to idiopathic membranous nephropathy.
New study finds that metastatic castration-sensitive prostate cancer patients who achieved a ≥90% reduction in PSA within 6 months of starting androgen receptor pathway inhibitors had significantly better survival and disease progression outcomes at 36 months. jheor.org/article/141170
July 29, 2025 at 6:41 PM
New study finds that metastatic castration-sensitive prostate cancer patients who achieved a ≥90% reduction in PSA within 6 months of starting androgen receptor pathway inhibitors had significantly better survival and disease progression outcomes at 36 months. jheor.org/article/141170
New UK-based study on health-related quality of life and work productivity in people with overweight or obesity finds that higher BMI and cardiovascular or metabolic comorbidities arere linked to reduced physical and mental functioning and lower productivity. #HEOR #obesity #overweight #HRQoL
July 24, 2025 at 3:46 PM
New UK-based study on health-related quality of life and work productivity in people with overweight or obesity finds that higher BMI and cardiovascular or metabolic comorbidities arere linked to reduced physical and mental functioning and lower productivity. #HEOR #obesity #overweight #HRQoL